Jingluweidai Information Consulting Service (Beijing) Co Ltd
发明人:
申请号：
EP18802608.2
公开号：
EP3611170A1
申请日:
2018.05.09
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention provides compounds as represented by structural formula (I). In formula (I), R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, and R14 are separately H or deuterium (D) independently. Moreover, at least one of R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, and R14 must be D. Also provided is use of any of the compounds or its pharmaceutical composition in the preparation of a drug for treating an anxiety.
